Cargando…

2795. Clinical and Economic Impact of a Ribavirin Intervention Program in Hematopoietic Cell and Solid-organ Transplant Recipients with Respiratory Syncytial Virus Infection

BACKGROUND: While data are limited, oral ribavirin (RBV) has been shown to be a cost-effective alternative to aerosolized RBV for the treatment of respiratory syncytial virus (RSV) in immunocompromised patients with significant reductions in acquisition and administration costs. We evaluated the cli...

Descripción completa

Detalles Bibliográficos
Autores principales:	Leonard, Emily, Wrenn, Rebekah, Saullo, Jennifer, Drew, Richard H, Sarubbi, Christina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2019
Materias:	Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6810415/ http://dx.doi.org/10.1093/ofid/ofz360.2472

Ejemplares similares

1600. An Optimal Respiratory Syncytial Virus (RSV) Treatment in Lung Transplant Recipients: Oral Ribavirin, Inhaled Ribavirin, or Conservative Approach
por: Permpalung, Nitipong, et al.
Publicado: (2018)

Risk factors for healthcare-associated Clostridium difficile infection in pediatric hematopoietic stem cell transplant recipients
por: Drew, Richard H, et al.
Publicado: (2017)

RIBAVIRIN AND RESPIRATORY SYNCYTIAL VIRUS
Publicado: (1986)

Antimicrobial Stewarding with a Unique Pharmacist-Managed Penicillin Skin Testing (PST) Service
por: Wrenn, Rebekah, et al.
Publicado: (2017)

Influence of Reported Penicillin Allergy on Mortality in MSSA Bacteremia
por: Turner, Nicholas A, et al.
Publicado: (2018)

1599. Rejection Outcomes in Lung Transplant Recipients Post Respiratory Syncytial Virus Infections
por: Permpalung, Nitipong, et al.
Publicado: (2018)

Respiratory syncytial virus in hematopoietic cell transplant recipients and patients with hematologic malignancies
por: Khawaja, Fareed, et al.
Publicado: (2019)

Respiratory syncytial virus pneumonia in a LDLT recipient transplanted for COVID 19 precipitated ACLF: Treated with ribavirin and IVIg
por: Kapoor, Sorabh, et al.
Publicado: (2022)

Respiratory Syncytial Virus Infection Morbidity in the Elderly: Time for Repurposing of Ribavirin?
por: de Zwart, Auke E S, et al.
Publicado: (2020)

Successful Treatment of Respiratory Syncytial Virus Infection in an Immunocompromised Patient With Ribavirin
por: Mir, Wasey Ali Yadullahi, et al.
Publicado: (2021)

Supplemental Oxygen–Free Days in Hematopoietic Cell Transplant Recipients With Respiratory Syncytial Virus
por: Waghmare, Alpana, et al.
Publicado: (2017)

Respiratory Syncytial Virus in Hematopoietic Cell Transplant Recipients: Factors Determining Progression to Lower Respiratory Tract Disease
por: Kim, Yae-Jean, et al.
Publicado: (2014)

Use of Oral Ribavirin for the Treatment of RSV Infections in Hematopoietic Cell Transplant (HCT) Recipients
por: Foolad, Farnaz, et al.
Publicado: (2017)

1243. Continuous vs. Intermittent Intraoperative Infusion of Cefazolin on Surgical Site Infections (SSIs) and Acute Kidney Injury in Patients Undergoing Cardiac Procedures
por: Tichy, Michael, et al.
Publicado: (2019)

Mortality Rates of Human Metapneumovirus and Respiratory Syncytial Virus Lower Respiratory Tract Infections in Hematopoietic Cell Transplantation Recipients
por: Renaud, Christian, et al.
Publicado: (2013)

A Phase 2, Randomized, Double-blind, Placebo-Controlled Trial of Presatovir for the Treatment of Respiratory Syncytial Virus Upper Respiratory Tract Infection in Hematopoietic-Cell Transplant Recipients
por: Chemaly, Roy F, et al.
Publicado: (2019)

193. Duration of Antimicrobial Therapy: The Impact of Defaults
por: Wrenn, Rebekah, et al.
Publicado: (2018)

923. Respiratory Syncytial and Parainfluenza Virus Infection Increase the Risk of Cytomegalovirus Reactivation in Allogeneic Hematopoietic Cell Transplant Recipients
por: Xie, Hu, et al.
Publicado: (2021)

Impact of a Standardized Penicillin Allergy Assessment Program to Optimize Penicillin Allergy Documentation and Β-lactam Antibiotic Use at an Academic Medical Center
por: Hanna, Sandra, et al.
Publicado: (2017)

Respiratory Syncytial Virus Lower Respiratory Disease in Hematopoietic Cell Transplant Recipients: Viral RNA Detection in Blood, Antiviral Treatment, and Clinical Outcomes
por: Waghmare, Alpana, et al.
Publicado: (2013)

1006. Do Antibiotic Choices Made in the ED Influence Inpatient Therapy?
por: Jones, Travis M, et al.
Publicado: (2019)

Respiratory Syncytial Virus and Human Metapneumovirus Infection in Transplant Recipients
por: Renaud, Christian, et al.
Publicado: (2016)

Review of respiratory syncytial virus infection among older adults and transplant recipients
por: Villanueva, Daphne-Dominique H., et al.
Publicado: (2022)

195. Economic and Clinical Burden of Respiratory Virus Infections in Allogeneic Hematopoietic Cell Transplantation Recipients
por: Ison, Michael G, et al.
Publicado: (2020)

204. Impact of Education and Data Feedback Interventions on Outpatient Prescribing for Urinary Tract Infections
por: Funaro, Jason, et al.
Publicado: (2018)

1107. Impact of Routine Education and Data Feedback on the Durability of an Antimicrobial Stewardship Intervention for Outpatient Urinary Tract Infections
por: Funaro, Jason, et al.
Publicado: (2019)

Immunogenicity of Inactivated Varicella Zoster Vaccine in Autologous Hematopoietic Stem Cell Transplant Recipients and Patients With Solid or Hematologic Cancer
por: Boeckh, Michael J, et al.
Publicado: (2020)

La fibroscopie digestive haute chez 2795 patients au centre hospitalier universitaire-campus de Lomé: les particularités selon le sexe
por: Lawson-Ananissoh, Laté Mawuli, et al.
Publicado: (2014)

2712. Respiratory syncytial virus (RSV) pre-fusion F antibody titers in hematopoietic cell transplant recipients with upper versus lower respiratory tract infections
por: Kim, Sara R, et al.
Publicado: (2023)

1878. Title: Impact of Antibiotic Stewardship Rounds in the Intensive Care Setting: A Prospective Cluster-Randomized Crossover Study
por: Seidelman, Jessica, et al.
Publicado: (2019)

Respiratory syncytial virus‐associated acute respiratory illness in adult non‐immunocompromised patients: Outcomes, determinants of outcomes, and the effect of oral ribavirin treatment
por: Wongsurakiat, Phunsup, et al.
Publicado: (2022)

Epidemiology of Respiratory Viral Infections in Pediatric Solid Organ Transplant or Hematopoietic Stem Cell Transplant Recipients
por: Fisher, Brian T., et al.
Publicado: (2015)

Investigating the Influence of Ribavirin on Human Respiratory Syncytial Virus RNA Synthesis by Using a High-Resolution Transcriptome Sequencing Approach
por: Aljabr, Waleed, et al.
Publicado: (2016)

Inpatient plus Post-discharge Durations of Therapy to Identify Antimicrobial Stewardship Opportunities at Transitions of Care
por: Dyer, April, et al.
Publicado: (2017)

2795. Cefepime Versus Meropenem for Infections Due to HECCcK-YeS-MAm Organisms with Cefepime MICs of 4-8 mCg/mL (S-DD)
por: Purdy, Andrew Scott, et al.
Publicado: (2023)

Impact of Education and Data Feedback on Guideline-Concordant Prescribing for Urinary Tract Infections in the Outpatient Setting
por: Funaro, Jason R, et al.
Publicado: (2021)

Tuberculosis in Pediatric Solid Organ and Hematopoietic Stem Cell Recipients
por: Dubois, Melanie, et al.
Publicado: (2021)

Possible therapeutic effect of orally administered ribavirin for respiratory syncytial virus-induced acute respiratory distress syndrome in an immunocompetent patient: a case report
por: Yoon, Byung Woo, et al.
Publicado: (2017)

Clinical and Economic Burden of Respiratory Viral Infections in Hematopoietic Stem Cell Transplant Recipients: The MD Anderson Experience
por: Ghantoji, Shashank S, et al.
Publicado: (2017)

Respiratory Virus Infections in Hematopoietic Cell Transplant Recipients
por: Pochon, Cécile, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_b2esio5b9lhkptdmt81aup2csq